- Home
- INBX vs BNY Comparison
INBX vs BNY Comparison
Compare INBX & BNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INBX | BNY |
|---|---|---|
| Founded | 2010 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 430.2M | 246.7M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | INBX | BNY |
|---|---|---|
| Price | $79.02 | $10.10 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 242.1K | 52.7K |
| Earning Date | 11-14-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.93% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,400,000.00 | N/A |
| Revenue This Year | $563.00 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $10.81 | $8.60 |
| 52 Week High | $94.57 | $10.80 |
Technical Indicators
Market Signals| Indicator | INBX | BNY |
|---|---|---|
| Relative Strength Index (RSI) | 48.06 | 44.67 |
| Support Level | $76.22 | $10.10 |
| Resistance Level | $94.57 | $10.23 |
| Average True Range (ATR) | 6.98 | 0.07 |
| MACD | -1.37 | -0.01 |
| Stochastic Oscillator | 21.45 | 27.27 |
Price Performance
Historical ComparisonAbout INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
About BNY BlackRock New York Municipal Income Trust
Blackrock NY Municipal Income Tr investment objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes and New York State and New York City personal income taxes as is consistent with its investment policies and prudent investment management.